Roche | Roche’s Virtual Event "Digitalization along the value chain"

Roche’s virtual analyst event during ESMO IO

Agenda

Welcome

CITYSCAPE updated analysis: Tiragolumab + Tecentriq in 1L NSCLC

Tiragolumab development overview

Q&A

Karl Mahler, Head of Investor Relations

Raymond Meng, M.D., Ph.D. - Global Development Leader Tiragolumab

Heather Stevens, MBA, MPH - Life Cycle Leader, Tiragolumab

Please register here to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Investors

Roche has hosted a virtual event on Friday, 10 December 2021.

Downloads

PDF